Drug Discovery Unchained: What The Drug!? #2

webinar

Wed, 14 Aug 2024, 16:00 CEST (Berlin)

Dr. Alexander Neumann, BioSolveIT, Germany

Drug Discovery Unchained: What The Drug!? #2

What happens when somebody asks you to do drug discovery? No preparation, no script, no nothing. Just live performing and sharing your thoughts.

This is “What The Drug!?”: a live session tackling a drug discovery challenge using BioSolveIT tools, with the aim of reaching a conclusion in a reasonable time frame. What is the challenge? We do not know. Everything will be revealed during the stream, and we will see how things unfold.

The first session was a good starting point, but let’s see how things develop. Dive into the session, discuss together, and explore on-the-fly compound design.

Current news

Tool of the Month - infiniSee 7.1 'Arke'
May 27, 2026 09:44 CEST
Navigate Chemical Space with infiniSee 7.1 ‘Arke’ The ultimate platform for exploring ultra-large Chemical Spaces is taking a huge leap forward. Combining our Tool of the Month series with an exciting software release, we are happy to present infiniSee 7.1 ‘Arke’. Allowing you to search deeper and evaluate compounds more...
Read on
category
Software
infiniSee 7.1 'Arke' Is Now Available
May 26, 2026 16:49 CEST
We are delighted to introduce infiniSee 7.1 ‘Arke’, another helpful step forward in making the exploration of vast Chemical Spaces faster, clearer, and more intuitive. With this update, we focused on two central goals: helping users move through ultra-large Chemical Spaces more efficiently and making compound assessment more visual and...
Read on
VAST™ Space by XtalPi - Access now with our tools
May 21, 2026 10:42 CEST
The VAST™ Space brings an actionable, navigable universe of 4.66 billion accessible, drug-like products directly into your workflow. Created by XtalPi, this collection was built from 40+ validated reaction protocols and 58,000 in-stock building blocks. By pairing automated synthesis with proprietary feasibility models, it delivers a highly reliable and innovative...
Read on